West Pharmaceutical Servi... (WST)
West Pharmaceutical Services Statistics
Share Statistics
West Pharmaceutical Services has 72.42M shares outstanding. The number of shares has increased by -1.07% in one year.
| Shares Outstanding | 72.42M |
| Shares Change (YoY) | -1.07% |
| Shares Change (QoQ) | -0.16% |
| Owned by Institutions (%) | 92.9% |
| Shares Floating | 71.98M |
| Failed to Deliver (FTD) Shares | 21 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 1.50M, so 2.07% of the outstanding shares have been sold short.
| Short Interest | 1.50M |
| Short % of Shares Out | 2.07% |
| Short % of Float | 2.09% |
| Short Ratio (days to cover) | 2.78 |
Valuation Ratios
The PE ratio is 48.53 and the forward PE ratio is 45.66. West Pharmaceutical Services 's PEG ratio is -3.13.
| PE Ratio | 48.53 |
| Forward PE | 45.66 |
| PS Ratio | 8.26 |
| Forward PS | 4.1 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | -3.13 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for West Pharmaceutical Services Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.91, with a Debt / Equity ratio of 0.
| Current Ratio | 5.91 |
| Quick Ratio | 4.33 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 189.97 |
Financial Efficiency
Return on equity (ROE) is 0% and return on capital (ROIC) is null%.
| Return on Equity (ROE) | 0% |
| Return on Assets (ROA) | 0.35% |
| Return on Capital (ROIC) | null% |
| Revenue Per Employee | 272.94K |
| Profits Per Employee | 46.48K |
| Employee Count | 10.60K |
| Asset Turnover | 2.05 |
| Inventory Turnover | 5.03 |
Taxes
| Income Tax | 107.50M |
| Effective Tax Rate | 0.18 |
Stock Price Statistics
The stock price has increased by -42.89% in the last 52 weeks. The beta is 1, so West Pharmaceutical Services 's price volatility has been higher than the market average.
| Beta | 1 |
| 52-Week Price Change | -42.89% |
| 50-Day Moving Average | 322.22 |
| 200-Day Moving Average | 317.43 |
| Relative Strength Index (RSI) | 17.58 |
| Average Volume (20 Days) | 695.50K |
Income Statement
In the last 12 months, West Pharmaceutical Services had revenue of 2.89B and earned 492.70M in profits. Earnings per share was 6.75.
| Revenue | 2.89B |
| Gross Profit | 998.50M |
| Operating Income | 569.90M |
| Net Income | 492.70M |
| EBITDA | 569.90M |
| EBIT | 569.90M |
| Earnings Per Share (EPS) | 6.75 |
Balance Sheet
The company has 484.60M in cash and 0 in debt, giving a net cash position of 484.60M.
| Cash & Cash Equivalents | 484.60M |
| Total Debt | 0 |
| Net Cash | 484.60M |
| Retained Earnings | 0 |
| Total Assets | 3.68B |
| Working Capital | 1.03B |
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0.
| Operating Cash Flow | 0 |
| Capital Expenditures | 0 |
| Free Cash Flow | 0 |
| FCF Per Share | 0 |
Margins
Gross margin is 34.51%, with operating and profit margins of 19.7% and 17.03%.
| Gross Margin | 34.51% |
| Operating Margin | 19.7% |
| Pretax Margin | 20.24% |
| Profit Margin | 17.03% |
| EBITDA Margin | 19.7% |
| EBIT Margin | 19.7% |
| FCF Margin | n/a |
Dividends & Yields
WST pays an annual dividend of $0.84, which amounts to a dividend yield of 0.41%.
| Dividend Per Share | $0.84 |
| Dividend Yield | 0.41% |
| Dividend Growth (YoY) | 5% |
| Payout Ratio | 12.54% |
| Earnings Yield | 3.32% |
| FCF Yield | 0% |
Analyst Forecast
The average price target for WST is $372.5, which is 83.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $372.5 |
| Price Target Difference | 83.1% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Stock Splits
The last stock split was on Sep 27, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 2013 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 12.66 |
| Piotroski F-Score | 5 |